Burning Rock Biotech Ltd - ADR

NASDAQ:BNR   3:59:50 PM EDT
12.84
-0.34 (-2.58%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.10B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$20.17 Million
Adjusted EPS-$0.25
See more estimates
10-Day MA$14.53
50-Day MA$18.28
200-Day MA$26.45
See more pivots

Burning Rock Biotech Ltd - ADR Stock, NASDAQ:BNR

601, 6/F, Building 3, Standard Industrial Unit 2, Guangzhou, Guangdong 510005
Phone: +86.20.34037871
Number of Employees: 938

Description

Burning Rock Biotech Ltd. engages in the investment of medical fields. It specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. The firm operates through the following segments: Central Laboratory Business, In-Hospital Business and Pharma Research and Development Services. Its products and clinical applications include companion diagnostics for targeted therapy and immunotherapy, benign, malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction and tumor susceptibility tests. The company was founded by Yu Sheng Han in January 2014 and is headquartered in Guangzhou, China.